Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (31)

Search Parameters:
Authors = M. Brunetti

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
33 pages, 35113 KB  
Article
Operation of a Modular 3D-Pixelated Liquid Argon Time-Projection Chamber in a Neutrino Beam
by S. Abbaslu, A. Abed Abud, R. Acciarri, L. P. Accorsi, M. A. Acero, M. R. Adames, G. Adamov, M. Adamowski, C. Adriano, F. Akbar, F. Alemanno, N. S. Alex, K. Allison, M. Alrashed, A. Alton, R. Alvarez, T. Alves, A. Aman, H. Amar, P. Amedo, J. Anderson, D. A. Andrade, C. Andreopoulos, M. Andreotti, M. P. Andrews, F. Andrianala, S. Andringa, F. Anjarazafy, S. Ansarifard, D. Antic, M. Antoniassi, A. Aranda-Fernandez, L. Arellano, E. Arrieta Diaz, M. A. Arroyave, M. Arteropons, J. Asaadi, M. Ascencio, A. Ashkenazi, D. Asner, L. Asquith, E. Atkin, D. Auguste, A. Aurisano, V. Aushev, D. Autiero, D. Ávila Gómez, M. B. Azam, F. Azfar, A. Back, J. J. Back, Y. Bae, I. Bagaturia, L. Bagby, D. Baigarashev, S. Balasubramanian, A. Balboni, P. Baldi, W. Baldini, J. Baldonedo, B. Baller, B. Bambah, F. Barao, D. Barbu, G. Barenboim, P. B̃arham Alzás, G. J. Barker, W. Barkhouse, G. Barr, A. Barros, N. Barros, D. Barrow, J. L. Barrow, A. Basharina-Freshville, A. Bashyal, V. Basque, M. Bassani, D. Basu, C. Batchelor, L. Bathe-Peters, J. B. R. Battat, F. Battisti, J. Bautista, F. Bay, J. L. L. Bazo Alba, J. F. Beacom, E. Bechetoille, B. Behera, E. Belchior, B. Bell, G. Bell, L. Bellantoni, G. Bellettini, V. Bellini, O. Beltramello, A. Belyaev, C. Benitez Montiel, D. Benjamin, F. Bento Neves, J. Berger, S. Berkman, J. Bermudez, J. Bernal, P. Bernardini, A. Bersani, E. Bertholet, E. Bertolini, S. Bertolucci, M. Betancourt, A. Betancur Rodríguez, Y. Bezawada, A. T. Bezerra, A. Bhat, V. Bhatnagar, M. Bhattacharjee, S. Bhattacharjee, M. Bhattacharya, S. Bhuller, B. Bhuyan, S. Biagi, J. Bian, K. Biery, B. Bilki, M. Bishai, A. Blake, F. D. Blaszczyk, G. C. Blazey, E. Blucher, B. Bogart, J. Boissevain, S. Bolognesi, T. Bolton, L. Bomben, M. Bonesini, C. Bonilla-Diaz, A. Booth, F. Boran, R. Borges Merlo, N. Bostan, G. Botogoske, B. Bottino, R. Bouet, J. Boza, J. Bracinik, B. Brahma, D. Brailsford, F. Bramati, A. Branca, A. Brandt, J. Bremer, S. J. Brice, V. Brio, C. Brizzolari, C. Bromberg, J. Brooke, A. Bross, G. Brunetti, M. B. Brunetti, N. Buchanan, H. Budd, J. Buergi, A. Bundock, D. Burgardt, S. Butchart, G. Caceres V., R. Calabrese, R. Calabrese, J. Calcutt, L. Calivers, E. Calvo, A. Caminata, A. F. Camino, W. Campanelli, A. Campani, A. Campos Benitez, N. Canci, J. Capó, I. Caracas, D. Caratelli, D. Carber, J. M. Carceller, G. Carini, B. Carlus, M. F. Carneiro, P. Carniti, I. Caro Terrazas, H. Carranza, N. Carrara, L. Carroll, T. Carroll, A. Carter, E. Casarejos, D. Casazza, J. F. Castaño Forero, F. A. Castaño, C. Castromonte, E. Catano-Mur, C. Cattadori, F. Cavalier, F. Cavanna, S. Centro, G. Cerati, C. Cerna, A. Cervelli, A. Cervera Villanueva, J. Chakrani, M. Chalifour, A. Chappell, A. Chatterjee, B. Chauhan, C. Chavez Barajas, H. Chen, M. Chen, W. C. Chen, Y. Chen, Z. Chen, D. Cherdack, S. S. Chhibra, C. Chi, F. Chiapponi, R. Chirco, N. Chitirasreemadam, K. Cho, S. Choate, G. Choi, D. Chokheli, P. S. Chong, B. Chowdhury, D. Christian, M. Chung, E. Church, M. F. Cicala, M. Cicerchia, V. Cicero, R. Ciolini, P. Clarke, G. Cline, A. G. Cocco, J. A. B. Coelho, A. Cohen, J. Collazo, J. Collot, H. Combs, J. M. Conrad, L. Conti, T. Contreras, M. Convery, K. Conway, S. Copello, P. Cova, C. Cox, L. Cremonesi, J. I. Crespo-Anadón, M. Crisler, E. Cristaldo, J. Crnkovic, G. Crone, R. Cross, A. Cudd, C. Cuesta, Y. Cui, F. Curciarello, D. Cussans, J. Dai, O. Dalager, W. Dallaway, R. D’Amico, H. da Motta, Z. A. Dar, R. Darby, L. Da Silva Peres, Q. David, G. S. Davies, S. Davini, J. Dawson, R. De Aguiar, P. Debbins, M. P. Decowski, A. de Gouvêa, P. C. De Holanda, P. De Jong, P. Del Amo Sanchez, G. De Lauretis, A. Delbart, M. Delgado, A. Dell’Acqua, G. Delle Monache, N. Delmonte, P. De Lurgio, R. Demario, G. De Matteis, J. R. T. de Mello Neto, A. P. A. De Mendonca, D. M. DeMuth, S. Dennis, C. Densham, P. Denton, G. W. Deptuch, A. De Roeck, V. De Romeri, J. P. Detje, J. Devine, K. Dhanmeher, R. Dharmapalan, M. Dias, A. Diaz, J. S. Díaz, F. Díaz, F. Di Capua, A. Di Domenico, S. Di Domizio, S. Di Falco, L. Di Giulio, P. Ding, L. Di Noto, E. Diociaiuti, G. Di Sciascio, V. Di Silvestre, C. Distefano, R. Di Stefano, R. Diurba, M. Diwan, Z. Djurcic, S. Dolan, M. Dolce, M. J. Dolinski, D. Domenici, S. Dominguez, S. Donati, S. Doran, D. Douglas, T. A. Doyle, F. Drielsma, D. Duchesneau, K. Duffy, K. Dugas, P. Dunne, B. Dutta, D. A. Dwyer, A. S. Dyshkant, S. Dytman, M. Eads, A. Earle, S. Edayath, D. Edmunds, J. Eisch, W. Emark, P. Englezos, A. Ereditato, T. Erjavec, C. O. Escobar, J. J. Evans, E. Ewart, A. C. Ezeribe, K. Fahey, A. Falcone, M. Fani’, D. Faragher, C. Farnese, Y. Farzan, J. Felix, Y. Feng, M. Ferreira da Silva, G. Ferry, E. Fialova, L. Fields, P. Filip, A. Filkins, F. Filthaut, G. Fiorillo, M. Fiorini, S. Fogarty, W. Foreman, J. Fowler, J. Franc, K. Francis, D. Franco, J. Franklin, J. Freeman, J. Fried, A. Friedland, M. Fucci, S. Fuess, I. K. Furic, K. Furman, A. P. Furmanski, R. Gaba, A. Gabrielli, A. M Gago, F. Galizzi, H. Gallagher, M. Galli, N. Gallice, V. Galymov, E. Gamberini, T. Gamble, R. Gandhi, S. Ganguly, F. Gao, S. Gao, D. Garcia-Gamez, M. Á. García-Peris, S. Gardiner, A. Gartman, A. Gauch, P. Gauzzi, S. Gazzana, G. Ge, N. Geffroy, B. Gelli, S. Gent, L. Gerlach, A. Ghosh, T. Giammaria, D. Gibin, I. Gil-Botella, A. Gioiosa, S. Giovannella, A. K. Giri, V. Giusti, D. Gnani, O. Gogota, S. Gollapinni, K. Gollwitzer, R. A. Gomes, L. S. Gomez Fajardo, D. Gonzalez-Diaz, J. Gonzalez-Santome, M. C. Goodman, S. Goswami, C. Gotti, J. Goudeau, C. Grace, E. Gramellini, R. Gran, P. Granger, C. Grant, D. R. Gratieri, G. Grauso, P. Green, S. Greenberg, W. C. Griffith, K. Grzelak, L. Gu, W. Gu, V. Guarino, M. Guarise, R. Guenette, M. Guerzoni, D. Guffanti, A. Guglielmi, F. Y. Guo, A. Gupta, V. Gupta, G. Gurung, D. Gutierrez, P. Guzowski, M. M. Guzzo, S. Gwon, A. Habig, L. Haegel, R. Hafeji, L. Hagaman, A. Hahn, J. Hakenmüller, T. Hamernik, P. Hamilton, J. Hancock, M. Handley, F. Happacher, B. Harris, D. A. Harris, L. Harris, A. L. Hart, J. Hartnell, T. Hartnett, J. Harton, T. Hasegawa, C. M. Hasnip, R. Hatcher, S. Hawkins, J. Hays, M. He, A. Heavey, K. M. Heeger, A. Heindel, J. Heise, P. Hellmuth, L. Henderson, K. Herner, V. Hewes, A. Higuera, A. Himmel, E. Hinkle, L. R. Hirsch, J. Ho, J. Hoefken Zink, J. Hoff, A. Holin, T. Holvey, C. Hong, S. Horiuchi, G. A. Horton-Smith, R. Hosokawa, T. Houdy, B. Howard, R. Howell, I. Hristova, M. S. Hronek, H. Hua, J. Huang, R. G. Huang, X. Huang, Z. Hulcher, A. Hussain, G. Iles, N. Ilic, A. M. Iliescu, R. Illingworth, G. Ingratta, A. Ioannisian, M. Ismerio Oliveira, C. M. Jackson, V. Jain, E. James, W. Jang, B. Jargowsky, D. Jena, I. Jentz, C. Jiang, J. Jiang, A. Jipa, J. H. Jo, F. R. Joaquim, W. Johnson, C. Jollet, R. Jones, N. Jovancevic, M. Judah, C. K. Jung, K. Y. Jung, T. Junk, Y. Jwa, M. Kabirnezhad, A. C. Kaboth, I. Kadenko, O. Kalikulov, D. Kalra, M. Kandemir, S. Kar, G. Karagiorgi, G. Karaman, A. Karcher, Y. Karyotakis, S. P. Kasetti, L. Kashur, A. Kauther, N. Kazaryan, L. Ke, E. Kearns, P. T. Keener, K. J. Kelly, R. Keloth, E. Kemp, O. Kemularia, Y. Kermaidic, W. Ketchum, S. H. Kettell, N. Khan, A. Khvedelidze, D. Kim, J. Kim, M. J. Kim, S. Kim, B. King, M. King, M. Kirby, A. Kish, J. Klein, J. Kleykamp, A. Klustova, T. Kobilarcik, L. Koch, K. Koehler, L. W. Koerner, D. H. Koh, M. Kordosky, T. Kosc, V. A. Kostelecký, I. Kotler, W. Krah, R. Kralik, M. Kramer, F. Krennrich, T. Kroupova, S. Kubota, M. Kubu, V. A. Kudryavtsev, G. Kufatty, S. Kuhlmann, A. Kumar, J. Kumar, M. Kumar, P. Kumar, P. Kumar, S. Kumaran, J. Kunzmann, V. Kus, T. Kutter, J. Kvasnicka, T. Labree, M. Lachat, T. Lackey, I. Lalău, A. Lambert, B. J. Land, C. E. Lane, N. Lane, K. Lang, T. Langford, M. Langstaff, F. Lanni, J. Larkin, P. Lasorak, D. Last, A. Laundrie, G. Laurenti, E. Lavaut, H. Lay, I. Lazanu, R. LaZur, M. Lazzaroni, S. Leardini, J. Learned, T. LeCompte, G. Lehmann Miotto, R. Lehnert, M. Leitner, H. Lemoine, D. Leon Silverio, L. M. Lepin, J.-Y. Li, S. W. Li, Y. Li, R. Lima, C. S. Lin, D. Lindebaum, S. Linden, R. A. Lineros, A. Lister, B. R. Littlejohn, J. Liu, Y. Liu, S. Lockwitz, I. Lomidze, K. Long, J. Lopez, I. López de Rego, N. López-March, J. M. LoSecco, A. Lozano Sanchez, X.-G. Lu, K. B. Luk, X. Luo, E. Luppi, A. A. Machado, P. Machado, C. T. Macias, J. R. Macier, M. MacMahon, S. Magill, C. Magueur, K. Mahn, A. Maio, N. Majeed, A. Major, K. Majumdar, A. Malige, S. Mameli, M. Man, R. C. Mandujano, J. Maneira, S. Manly, K. Manolopoulos, M. Manrique Plata, S. Manthey Corchado, L. Manzanillas-Velez, E. Mao, M. Marchan, A. Marchionni, D. Marfatia, C. Mariani, J. Maricic, F. Marinho, A. D. Marino, T. Markiewicz, F. Das Chagas Marques, M. Marshak, C. M. Marshall, J. Marshall, L. Martina, J. Martín-Albo, D. A. Martinez Caicedo, M. Martinez-Casales, F. Martínez López, S. Martynenko, V. Mascagna, A. Mastbaum, M. Masud, F. Matichard, G. Matteucci, J. Matthews, C. Mauger, N. Mauri, K. Mavrokoridis, I. Mawby, F. Mayhew, T. McAskill, N. McConkey, B. McConnell, K. S. McFarland, C. McGivern, C. McGrew, A. McNab, C. McNulty, J. Mead, L. Meazza, V. C. N. Meddage, A. Medhi, M. Mehmood, B. Mehta, P. Mehta, F. Mei, P. Melas, L. Mellet, T. C. D. Melo, O. Mena, H. Mendez, D. P. Méndez, A. Menegolli, G. Meng, A. C. E. A. Mercuri, A. Meregaglia, M. D. Messier, S. Metallo, W. Metcalf, M. Mewes, H. Meyer, T. Miao, J. Micallef, A. Miccoli, G. Michna, R. Milincic, F. Miller, G. Miller, W. Miller, A. Minotti, L. Miralles Verge, C. Mironov, S. Miscetti, C. S. Mishra, P. Mishra, S. R. Mishra, D. Mladenov, I. Mocioiu, A. Mogan, R. Mohanta, T. A. Mohayai, N. Mokhov, J. Molina, L. Molina Bueno, E. Montagna, A. Montanari, C. Montanari, D. Montanari, D. Montanino, L. M. Montaño Zetina, M. Mooney, A. F. Moor, M. Moore, Z. Moore, D. Moreno, G. Moreno-Granados, O. Moreno-Palacios, L. Morescalchi, C. Morris, E. Motuk, C. A. Moura, G. Mouster, W. Mu, L. Mualem, J. Mueller, M. Muether, A. Muir, Y. Mukhamejanov, A. Mukhamejanova, M. Mulhearn, D. Munford, L. J. Munteanu, H. Muramatsu, J. Muraz, M. Murphy, T. Murphy, A. Mytilinaki, J. Nachtman, Y. Nagai, S. Nagu, D. Naples, S. Narita, J. Nava, A. Navrer-Agasson, N. Nayak, M. Nebot-Guinot, A. Nehm, J. K. Nelson, O. Neogi, J. Nesbit, M. Nessi, D. Newbold, M. Newcomer, D. Newmark, R. Nichol, F. Nicolas-Arnaldos, A. Nielsen, A. Nikolica, J. Nikolov, E. Niner, X. Ning, K. Nishimura, A. Norman, A. Norrick, P. Novella, A. Nowak, J. A. Nowak, M. Oberling, J. P. Ochoa-Ricoux, S. Oh, S. B. Oh, A. Olivier, T. Olson, Y. Onel, Y. Onishchuk, A. Oranday, M. Osbiston, J. A. Osorio Vélez, L. O’Sullivan, L. Otiniano Ormachea, L. Pagani, G. Palacio, O. Palamara, S. Palestini, J. M. Paley, M. Pallavicini, C. Palomares, S. Pan, M. Panareo, P. Panda, V. Pandey, W. Panduro Vazquez, E. Pantic, V. Paolone, A. Papadopoulou, R. Papaleo, D. Papoulias, S. Paramesvaran, J. Park, S. Parke, S. Parsa, S. Parveen, M. Parvu, D. Pasciuto, S. Pascoli, L. Pasqualini, J. Pasternak, G. Patel, J. L. Paton, C. Patrick, L. Patrizii, R. B. Patterson, T. Patzak, A. Paudel, J. Paul, L. Paulucci, Z. Pavlovic, G. Pawloski, D. Payne, A. Peake, V. Pec, E. Pedreschi, S. J. M. Peeters, W. Pellico, E. Pennacchio, A. Penzo, O. L. G. Peres, Y. F. Perez Gonzalez, L. Pérez-Molina, C. Pernas, J. Perry, D. Pershey, G. Pessina, G. Petrillo, C. Petta, R. Petti, M. Pfaff, V. Pia, G. M. Piacentino, L. Pickering, L. Pierini, F. Pietropaolo, V. L. Pimentel, G. Pinaroli, S. Pincha, J. Pinchault, K. Pitts, P. Plesniak, K. Pletcher, K. Plows, C. Pollack, T. Pollmann, F. Pompa, X. Pons, N. Poonthottathil, V. Popov, F. Poppi, J. Porter, L. G. Porto Paixão, M. Potekhin, M. Pozzato, R. Pradhan, T. Prakash, M. Prest, F. Psihas, D. Pugnere, D. Pullia, X. Qian, J. Queen, J. L. Raaf, M. Rabelhofer, V. Radeka, J. Rademacker, F. Raffaelli, A. Rafique, A. Rahe, S. Rajagopalan, M. Rajaoalisoa, I. Rakhno, L. Rakotondravohitra, M. A. Ralaikoto, L. Ralte, M. A. Ramirez Delgado, B. Ramson, S. S. Randriamanampisoa, A. Rappoldi, G. Raselli, T. Rath, P. Ratoff, R. Ray, H. Razafinime, R. F. Razakamiandra, E. M. Rea, J. S. Real, B. Rebel, R. Rechenmacher, J. Reichenbacher, S. D. Reitzner, E. Renner, S. Repetto, S. Rescia, F. Resnati, C. Reynolds, M. Ribas, S. Riboldi, C. Riccio, G. Riccobene, J. S. Ricol, M. Rigan, A. Rikalo, E. V. Rincón, A. Ritchie-Yates, D. Rivera, A. Robert, A. Roberts, E. Robles, M. Roda, D. Rodas Rodríguez, M. J. O. Rodrigues, J. Rodriguez Rondon, S. Rosauro-Alcaraz, P. Rosier, D. Ross, M. Rossella, M. Ross-Lonergan, T. Rotsy, N. Roy, P. Roy, P. Roy, C. Rubbia, D. Rudik, A. Ruggeri, G. Ruiz Ferreira, K. Rushiya, B. Russell, S. Sacerdoti, N. Saduyev, S. K. Sahoo, N. Sahu, S. Sakhiyev, P. Sala, G. Salmoria, S. Samanta, M. C. Sanchez, A. Sánchez-Castillo, P. Sanchez-Lucas, D. A. Sanders, S. Sanfilippo, D. Santoro, N. Saoulidou, P. Sapienza, I. Sarcevic, I. Sarra, G. Savage, V. Savinov, G. Scanavini, A. Scanu, A. Scaramelli, T. Schefke, H. Schellman, S. Schifano, P. Schlabach, D. Schmitz, A. W. Schneider, K. Scholberg, A. Schroeder, A. Schukraft, B. Schuld, S. Schwartz, A. Segade, E. Segreto, A. Selyunin, C. R. Senise, J. Sensenig, S. H. Seo, D. Seppela, M. H. Shaevitz, P. Shanahan, P. Sharma, R. Kumar, S. Sharma Poudel, K. Shaw, T. Shaw, K. Shchablo, J. Shen, C. Shepherd-Themistocleous, J. Shi, W. Shi, S. Shin, S. Shivakoti, A. Shmakov, I. Shoemaker, D. Shooltz, R. Shrock, M. Siden, J. Silber, L. Simard, J. Sinclair, G. Sinev, Jaydip Singh, J. Singh, L. Singh, P. Singh, V. Singh, S. Singh Chauhan, R. Sipos, C. Sironneau, G. Sirri, K. Siyeon, K. Skarpaas, J. Smedley, J. Smith, P. Smith, J. Smolik, M. Smy, M. Snape, E. L. Snider, P. Snopok, M. Soares Nunes, H. Sobel, M. Soderberg, H. Sogarwal, C. J. Solano Salinas, S. Söldner-Rembold, N. Solomey, V. Solovov, W. E. Sondheim, M. Sorbara, M. Sorel, J. Soto-Oton, A. Sousa, K. Soustruznik, D. Souza Correia, F. Spinella, J. Spitz, N. J. C. Spooner, D. Stalder, M. Stancari, L. Stanco, J. Steenis, R. Stein, H. M. Steiner, A. F. Steklain Lisbôa, J. Stewart, B. Stillwell, J. Stock, T. Stokes, T. Strauss, L. Strigari, A. Stuart, J. G. Suarez, J. Subash, A. Surdo, L. Suter, A. Sutton, K. Sutton, Y. Suvorov, R. Svoboda, S. K. Swain, C. Sweeney, B. Szczerbinska, A. M. Szelc, A. Sztuc, A. Taffara, N. Talukdar, J. Tamara, H. A. Tanaka, S. Tang, N. Taniuchi, A. M. Tapia Casanova, A. Tapper, S. Tariq, E. Tatar, R. Tayloe, A. M. Teklu, K. Tellez Giron Flores, J. Tena Vidal, P. Tennessen, M. Tenti, K. Terao, F. Terranova, G. Testera, T. Thakore, A. Thea, S. Thomas, A. Thompson, C. Thorpe, S. C. Timm, E. Tiras, V. Tishchenko, S. Tiwari, N. Todorović, L. Tomassetti, A. Tonazzo, D. Torbunov, D. Torres Muñoz, M. Torti, M. Tortola, Y. Torun, N. Tosi, D. Totani, M. Toups, C. Touramanis, V. Trabattoni, D. Tran, J. Trevor, E. Triller, S. Trilov, D. Trotta, J. Truchon, D. Truncali, W. H. Trzaska, Y. Tsai, Y.-T. Tsai, Z. Tsamalaidze, K. V. Tsang, N. Tsverava, S. Z. Tu, S. Tufanli, C. Tunnell, J. Turner, M. Tuzi, M. Tzanov, M. A. Uchida, J. Ureña González, J. Urheim, T. Usher, H. Utaegbulam, S. Uzunyan, M. R. Vagins, P. Vahle, G. A. Valdiviesso, E. Valencia, R. Valentim, Z. Vallari, E. Vallazza, J. W. F. Valle, R. Van Berg, D. V. Forero, A. Vannozzi, M. Van Nuland-Troost, F. Varanini, D. Vargas Oliva, N. Vaughan, K. Vaziri, A. Vázquez-Ramos, J. Vega, J. Vences, S. Ventura, A. Verdugo, M. Verzocchi, K. Vetter, M. Vicenzi, H. Vieira de Souza, C. Vignoli, C. Vilela, E. Villa, S. Viola, B. Viren, G. V. Stenico, R. Vizarreta, A. P. Vizcaya Hernandez, S. Vlachos, G. Vorobyev, Q. Vuong, A. V. Waldron, L. Walker, H. Wallace, M. Wallach, J. Walsh, T. Walton, L. Wan, B. Wang, H. Wang, J. Wang, M. H. L. S. Wang, X. Wang, Y. Wang, D. Warner, L. Warsame, M. O. Wascko, D. Waters, A. Watson, K. Wawrowska, A. Weber, C. M. Weber, M. Weber, H. Wei, A. Weinstein, S. Westerdale, M. Wetstein, K. Whalen, A. J. White, L. H. Whitehead, D. Whittington, F. Wieler, J. Wilhlemi, M. J. Wilking, A. Wilkinson, C. Wilkinson, F. Wilson, R. J. Wilson, P. Winter, J. Wolcott, J. Wolfs, T. Wongjirad, A. Wood, K. Wood, E. Worcester, M. Worcester, K. Wresilo, M. Wright, M. Wrobel, S. Wu, W. Wu, Z. Wu, M. Wurm, J. Wyenberg, B. M. Wynne, Y. Xiao, I. Xiotidis, B. Yaeggy, N. Yahlali, E. Yandel, G. Yang, J. Yang, T. Yang, A. Yankelevich, L. Yates, U. Yevarouskaya, K. Yonehara, T. Young, B. Yu, H. Yu, J. Yu, W. Yuan, M. Zabloudil, R. Zaki, J. Zalesak, L. Zambelli, B. Zamorano, A. Zani, O. Zapata, L. Zazueta, G. P. Zeller, J. Zennamo, J. Zettlemoyer, K. Zeug, C. Zhang, S. Zhang, Y. Zhang, L. Zhao, M. Zhao, E. D. Zimmerman, S. Zucchelli, V. Zutshi, R. Zwaska and On behalf of the DUNE Collaborationadd Show full author list remove Hide full author list
Instruments 2026, 10(1), 18; https://doi.org/10.3390/instruments10010018 - 17 Mar 2026
Viewed by 772
Abstract
The 2x2 Demonstrator, a prototype for the Deep Underground Neutrino Experiment (DUNE) liquid argon (LAr) Near Detector, was exposed to the Neutrinos from the Main Injector (NuMI) neutrino beam at Fermi National Accelerator Laboratory (Fermilab). This detector is a prototype of a new [...] Read more.
The 2x2 Demonstrator, a prototype for the Deep Underground Neutrino Experiment (DUNE) liquid argon (LAr) Near Detector, was exposed to the Neutrinos from the Main Injector (NuMI) neutrino beam at Fermi National Accelerator Laboratory (Fermilab). This detector is a prototype of a new modular design for a liquid argon time-projection chamber (LArTPC), comprising a two-by-two array of four modules, each further segmented into two optically isolated LArTPCs. The 2x2 Demonstrator features a number of pioneering technologies, including a low-profile resistive field shell to establish drift fields, native 3D ionization pixelated imaging, and a high-coverage dielectric light readout system. The 2.4-tonne active mass detector is flanked upstream and downstream by supplemental solid-scintillator tracking planes, repurposed from the MINERvA experiment, which track ionizing particles exiting the argon volume. The antineutrino beam data collected by the detector over a 4.5 day period in 2024 include over 30,000 neutrino interactions in the LAr active volume—the first neutrino interactions reported by a DUNE detector prototype. During its physics-quality run, the 2x2 Demonstrator operated at a nominal drift field of 500 V/cm and maintained good LAr purity, with a stable electron lifetime of approximately 1.25 ms. This paper describes the detector and supporting systems, summarizes the installation and commissioning, and presents the initial validation of collected NuMI beam and off-beam self-triggers. In addition, it highlights observed interactions in the detector volume, including candidate muon antineutrino events. Full article
Show Figures

Figure 1

13 pages, 3020 KB  
Article
Cytokinins Are Age- and Injury-Responsive Molecules That Regulate Skeletal Myogenesis
by Farnoush Kabiri, Zeynab Azimychetabi, Dev Seneviratne, Lorna N. Phan, Hannah M. Kavanagh, Hannah C. Smith, R. J. Neil Emery, Craig R. Brunetti, Janet Yee and Stephanie W. Tobin
Int. J. Mol. Sci. 2025, 26(20), 10136; https://doi.org/10.3390/ijms262010136 - 18 Oct 2025
Viewed by 923
Abstract
Myogenesis is a tightly regulated process essential for embryonic development, postnatal growth, and muscle regeneration. We recently identified that cytokinins (CTKs), a class of adenine-derived signaling molecules originally characterized in plants, are present in cultured skeletal muscle cells. The most abundant type of [...] Read more.
Myogenesis is a tightly regulated process essential for embryonic development, postnatal growth, and muscle regeneration. We recently identified that cytokinins (CTKs), a class of adenine-derived signaling molecules originally characterized in plants, are present in cultured skeletal muscle cells. The most abundant type of cytokinins detected within cultured muscle cells was isopentenyladenine (iP) in its nucleotide, riboside, and free base derivatives. The purpose of this study was to determine whether CTKs are also present in regenerating muscle tissue in vivo and to characterize the effects of iP and its riboside form, isopentenyladenosine (iPR), on muscle cell proliferation and differentiation. These effects were observed relative to adenine and adenosine, and to a second class of cytokinins with a large aromatic side chain, kinetin (the free base), and kinetin riboside. Cardiotoxin was used to induce muscle injury and repair processes in the gastrocnemius of 3- and 12-month-old mice. Samples were collected 3- and 7 days post-injury for ultra high-performance liquid chromatography tandem mass spectrometry with electrospray ionization (UHPLC-(ESI+)-HRMS/MS). Four CTKs (N6-benzyladenine (BA), dihydrozeatin-9-N-glucoside (DZ9G), isopentenyladenosine (iPR), and 2-methylthio-isopentenyladenosine (2-MeSiPR) were detected. 2-MeSiPR levels were significantly influenced by aging, as this CTK was increased in response to injury only in the younger mice. Treatment of C2C12 myoblasts with 10 µM of isopentenyladenosine (iPR) or kinetin riboside reduced cell proliferation, whereas iP (the free base) increased proliferation in a biphasic response. During differentiation, both iPR and kinetin riboside impaired myotube formation, while the free-base forms of iP and kinetin had no effect. Our data establishes that CTKs are present within muscle tissue and highly responsive to injury and aging. Furthermore, the biological activities of CTKs in muscle cells are influenced by structural modifications, including riboside conjugation and side chain composition. Understanding these differences provides insight into the distinct roles of CTKs in muscle cell metabolism and differentiation, offering potential implications for the use of exogenous CTKs in muscle biology and regenerative medicine. Full article
(This article belongs to the Section Molecular Pharmacology)
Show Figures

Figure 1

27 pages, 7745 KB  
Article
Single-Cell Profiling Reveals Global Immune Responses During the Progression of Murine Epidermal Neoplasms
by Xiying Fan, Tonya M. Brunetti, Kelsey Jackson and Dennis R. Roop
Cancers 2025, 17(8), 1379; https://doi.org/10.3390/cancers17081379 - 21 Apr 2025
Cited by 3 | Viewed by 2084
Abstract
Background/Objectives: Immune cells determine the role of the tumor microenvironment during tumor progression, either suppressing tumor formation or promoting tumorigenesis. This study aimed to fully characterize immune cell responses during skin tumor progression. Methods: Using single-cell RNA sequencing, we analyzed the profile of [...] Read more.
Background/Objectives: Immune cells determine the role of the tumor microenvironment during tumor progression, either suppressing tumor formation or promoting tumorigenesis. This study aimed to fully characterize immune cell responses during skin tumor progression. Methods: Using single-cell RNA sequencing, we analyzed the profile of immune cells in the tumor microenvironment of control mouse skins and skin tumors at the single-cell level. Results: We identified 15 CD45+ immune cell clusters, which broadly represent the most functionally characterized immune cell types including macrophages, Langerhans cells (LC), conventional type 1 dendritic cells (cDC1), conventional type 2 dendritic cells (cDC2), migratory/mature dendritic cells (mDC), dendritic epidermal T cells (DETC), dermal γδ T cells (γδT), T cells, regulatory T cells (Tregs), natural killer cells (NK), type 2 innate lymphoid cells (ILC2), neutrophils (Neu), mast cells (Mast), and two proliferating populations (Prolif.1 and Prolif.2). Skin tumor progression reprogramed immune cells and led to a marked increase in the relative percentages of macrophages, cDC2, mDC, Tregs, and Neu. Macrophages, the largest cell cluster of immune cells in skin tumors. In addition, macrophages emerged as the predominant communication ‘hub’ in skin tumors, highlighting the importance of macrophages during skin tumor progression. In contrast, other immune cell clusters decreased during skin tumor progression, including DETC, γδT, ILC2, and LC. In addition, skin tumor progression dramatically upregulated Jak2/Stat3 expression and the interferon response across various immune cell clusters. Further, skin tumor progression activated T cells and NK cells indicated by elevated expression of IFN-γ and Granzyme B in skin tumors. Meanwhile, a pronounced infiltration of M2-macrophages and Tregs in skin tumors created an immunosuppressive microenvironment, consistent with the elevated expression of the Stat3 pathway in skin tumors. Conclusions: Our study elucidates the immune cell landscape of epidermal neoplasms, offering a comprehensive understanding of the immune response during skin tumor progression and providing new insights into cancer immune evasion mechanisms. Full article
(This article belongs to the Special Issue The Tumor Microenvironment: Interplay Between Immune Cells)
Show Figures

Figure 1

45 pages, 30346 KB  
Article
Performance of a Modular Ton-Scale Pixel-Readout Liquid Argon Time Projection Chamber
by A. Abed Abud, B. Abi, R. Acciarri, M. A. Acero, M. R. Adames, G. Adamov, M. Adamowski, D. Adams, M. Adinolfi, C. Adriano, A. Aduszkiewicz, J. Aguilar, B. Aimard, F. Akbar, K. Allison, S. Alonso Monsalve, M. Alrashed, A. Alton, R. Alvarez, T. Alves, H. Amar, P. Amedo, J. Anderson, D. A. Andrade, C. Andreopoulos, M. Andreotti, M. P. Andrews, F. Andrianala, S. Andringa, N. Anfimov, A. Ankowski, M. Antoniassi, M. Antonova, A. Antoshkin, A. Aranda-Fernandez, L. Arellano, E. Arrieta Diaz, M. A. Arroyave, J. Asaadi, A. Ashkenazi, D. Asner, L. Asquith, E. Atkin, D. Auguste, A. Aurisano, V. Aushev, D. Autiero, F. Azfar, A. Back, H. Back, J. J. Back, I. Bagaturia, L. Bagby, N. Balashov, S. Balasubramanian, P. Baldi, W. Baldini, J. Baldonedo, B. Baller, B. Bambah, R. Banerjee, F. Barao, G. Barenboim, P. B̃arham Alzás, G. J. Barker, W. Barkhouse, G. Barr, J. Barranco Monarca, A. Barros, N. Barros, D. Barrow, J. L. Barrow, A. Basharina-Freshville, A. Bashyal, V. Basque, C. Batchelor, L. Bathe-Peters, J. B. R. Battat, F. Battisti, F. Bay, M. C. Q. Bazetto, J. L. L. Bazo Alba, J. F. Beacom, E. Bechetoille, B. Behera, E. Belchior, G. Bell, L. Bellantoni, G. Bellettini, V. Bellini, O. Beltramello, N. Benekos, C. Benitez Montiel, D. Benjamin, F. Bento Neves, J. Berger, S. Berkman, J. Bernal, P. Bernardini, A. Bersani, S. Bertolucci, M. Betancourt, A. Betancur Rodríguez, A. Bevan, Y. Bezawada, A. T. Bezerra, T. J. Bezerra, A. Bhat, V. Bhatnagar, J. Bhatt, M. Bhattacharjee, M. Bhattacharya, S. Bhuller, B. Bhuyan, S. Biagi, J. Bian, K. Biery, B. Bilki, M. Bishai, A. Bitadze, A. Blake, F. D. Blaszczyk, G. C. Blazey, E. Blucher, J. Bogenschuetz, J. Boissevain, S. Bolognesi, T. Bolton, L. Bomben, M. Bonesini, C. Bonilla-Diaz, F. Bonini, A. Booth, F. Boran, S. Bordoni, R. Borges Merlo, A. Borkum, N. Bostan, J. Bracinik, D. Braga, B. Brahma, D. Brailsford, F. Bramati, A. Branca, A. Brandt, J. Bremer, C. Brew, S. J. Brice, V. Brio, C. Brizzolari, C. Bromberg, J. Brooke, A. Bross, G. Brunetti, M. Brunetti, N. Buchanan, H. Budd, J. Buergi, D. Burgardt, S. Butchart, G. Caceres V., I. Cagnoli, T. Cai, R. Calabrese, J. Calcutt, M. Calin, L. Calivers, E. Calvo, A. Caminata, A. F. Camino, W. Campanelli, A. Campani, A. Campos Benitez, N. Canci, J. Capó, I. Caracas, D. Caratelli, D. Carber, J. M. Carceller, G. Carini, B. Carlus, M. F. Carneiro, P. Carniti, I. Caro Terrazas, H. Carranza, N. Carrara, L. Carroll, T. Carroll, A. Carter, E. Casarejos, D. Casazza, J. F. Castaño Forero, F. A. Castaño, A. Castillo, C. Castromonte, E. Catano-Mur, C. Cattadori, F. Cavalier, F. Cavanna, S. Centro, G. Cerati, C. Cerna, A. Cervelli, A. Cervera Villanueva, K. Chakraborty, S. Chakraborty, M. Chalifour, A. Chappell, N. Charitonidis, A. Chatterjee, H. Chen, M. Chen, W. C. Chen, Y. Chen, Z. Chen-Wishart, D. Cherdack, C. Chi, R. Chirco, N. Chitirasreemadam, K. Cho, S. Choate, D. Chokheli, P. S. Chong, B. Chowdhury, D. Christian, A. Chukanov, M. Chung, E. Church, M. F. Cicala, M. Cicerchia, V. Cicero, R. Ciolini, P. Clarke, G. Cline, T. E. Coan, A. G. Cocco, J. A. B. Coelho, A. Cohen, J. Collazo, J. Collot, E. Conley, J. M. Conrad, M. Convery, S. Copello, P. Cova, C. Cox, L. Cremaldi, L. Cremonesi, J. I. Crespo-Anadón, M. Crisler, E. Cristaldo, J. Crnkovic, G. Crone, R. Cross, A. Cudd, C. Cuesta, Y. Cui, F. Curciarello, D. Cussans, J. Dai, O. Dalager, R. Dallavalle, W. Dallaway, H. da Motta, Z. A. Dar, R. Darby, L. Da Silva Peres, Q. David, G. S. Davies, S. Davini, J. Dawson, R. De Aguiar, P. De Almeida, P. Debbins, I. De Bonis, M. P. Decowski, A. de Gouvêa, P. C. De Holanda, I. L. De Icaza Astiz, P. De Jong, P. Del Amo Sanchez, A. De la Torre, G. De Lauretis, A. Delbart, D. Delepine, M. Delgado, A. Dell’Acqua, G. Delle Monache, N. Delmonte, P. De Lurgio, R. Demario, G. De Matteis, J. R. T. de Mello Neto, D. M. DeMuth, S. Dennis, C. Densham, P. Denton, G. W. Deptuch, A. De Roeck, V. De Romeri, J. P. Detje, J. Devine, R. Dharmapalan, M. Dias, A. Diaz, J. S. Díaz, F. Díaz, F. Di Capua, A. Di Domenico, S. Di Domizio, S. Di Falco, L. Di Giulio, P. Ding, L. Di Noto, E. Diociaiuti, C. Distefano, R. Diurba, M. Diwan, Z. Djurcic, D. Doering, S. Dolan, F. Dolek, M. J. Dolinski, D. Domenici, L. Domine, S. Donati, Y. Donon, S. Doran, D. Douglas, T. A. Doyle, A. Dragone, F. Drielsma, L. Duarte, D. Duchesneau, K. Duffy, K. Dugas, P. Dunne, B. Dutta, H. Duyang, D. A. Dwyer, A. S. Dyshkant, S. Dytman, M. Eads, A. Earle, S. Edayath, D. Edmunds, J. Eisch, P. Englezos, A. Ereditato, T. Erjavec, C. O. Escobar, J. J. Evans, E. Ewart, A. C. Ezeribe, K. Fahey, L. Fajt, A. Falcone, M. Fani’, C. Farnese, S. Farrell, Y. Farzan, D. Fedoseev, J. Felix, Y. Feng, E. Fernandez-Martinez, G. Ferry, L. Fields, P. Filip, A. Filkins, F. Filthaut, R. Fine, G. Fiorillo, M. Fiorini, S. Fogarty, W. Foreman, J. Fowler, J. Franc, K. Francis, D. Franco, J. Franklin, J. Freeman, J. Fried, A. Friedland, S. Fuess, I. K. Furic, K. Furman, A. P. Furmanski, R. Gaba, A. Gabrielli, A. M. Gago, F. Galizzi, H. Gallagher, A. Gallas, N. Gallice, V. Galymov, E. Gamberini, T. Gamble, F. Ganacim, R. Gandhi, S. Ganguly, F. Gao, S. Gao, D. Garcia-Gamez, M. Á. García-Peris, F. Gardim, S. Gardiner, D. Gastler, A. Gauch, J. Gauvreau, P. Gauzzi, S. Gazzana, G. Ge, N. Geffroy, B. Gelli, S. Gent, L. Gerlach, Z. Ghorbani-Moghaddam, T. Giammaria, D. Gibin, I. Gil-Botella, S. Gilligan, A. Gioiosa, S. Giovannella, C. Girerd, A. K. Giri, C. Giugliano, V. Giusti, D. Gnani, O. Gogota, S. Gollapinni, K. Gollwitzer, R. A. Gomes, L. V. Gomez Bermeo, L. S. Gomez Fajardo, F. Gonnella, D. Gonzalez-Diaz, M. Gonzalez-Lopez, M. C. Goodman, S. Goswami, C. Gotti, J. Goudeau, E. Goudzovski, C. Grace, E. Gramellini, R. Gran, E. Granados, P. Granger, C. Grant, D. R. Gratieri, G. Grauso, P. Green, S. Greenberg, J. Greer, W. C. Griffith, F. T. Groetschla, K. Grzelak, L. Gu, W. Gu, V. Guarino, M. Guarise, R. Guenette, E. Guerard, M. Guerzoni, D. Guffanti, A. Guglielmi, B. Guo, Y. Guo, A. Gupta, V. Gupta, G. Gurung, D. Gutierrez, P. Guzowski, M. M. Guzzo, S. Gwon, A. Habig, H. Hadavand, L. Haegel, R. Haenni, L. Hagaman, A. Hahn, J. Haiston, J. Hakenmueller, T. Hamernik, P. Hamilton, J. Hancock, F. Happacher, D. A. Harris, J. Hartnell, T. Hartnett, J. Harton, T. Hasegawa, C. Hasnip, R. Hatcher, K. Hayrapetyan, J. Hays, E. Hazen, M. He, A. Heavey, K. M. Heeger, J. Heise, S. Henry, M. A. Hernandez Morquecho, K. Herner, V. Hewes, A. Higuera, C. Hilgenberg, S. J. Hillier, A. Himmel, E. Hinkle, L. R. Hirsch, J. Ho, J. Hoff, A. Holin, T. Holvey, E. Hoppe, S. Horiuchi, G. A. Horton-Smith, M. Hostert, T. Houdy, B. Howard, R. Howell, I. Hristova, M. S. Hronek, J. Huang, R. G. Huang, Z. Hulcher, M. Ibrahim, G. Iles, N. Ilic, A. M. Iliescu, R. Illingworth, G. Ingratta, A. Ioannisian, B. Irwin, L. Isenhower, M. Ismerio Oliveira, R. Itay, C. M. Jackson, V. Jain, E. James, W. Jang, B. Jargowsky, D. Jena, I. Jentz, X. Ji, C. Jiang, J. Jiang, L. Jiang, A. Jipa, F. R. Joaquim, W. Johnson, C. Jollet, B. Jones, R. Jones, D. José Fernández, N. Jovancevic, M. Judah, C. K. Jung, T. Junk, Y. Jwa, M. Kabirnezhad, A. C. Kaboth, I. Kadenko, I. Kakorin, A. Kalitkina, D. Kalra, M. Kandemir, D. M. Kaplan, G. Karagiorgi, G. Karaman, A. Karcher, Y. Karyotakis, S. Kasai, S. P. Kasetti, L. Kashur, I. Katsioulas, A. Kauther, N. Kazaryan, L. Ke, E. Kearns, P. T. Keener, K. J. Kelly, E. Kemp, O. Kemularia, Y. Kermaidic, W. Ketchum, S. H. Kettell, M. Khabibullin, N. Khan, A. Khvedelidze, D. Kim, J. Kim, M. Kim, B. King, B. Kirby, M. Kirby, A. Kish, J. Klein, J. Kleykamp, A. Klustova, T. Kobilarcik, L. Koch, K. Koehler, L. W. Koerner, D. H. Koh, L. Kolupaeva, D. Korablev, M. Kordosky, T. Kosc, U. Kose, V. A. Kostelecký, K. Kothekar, I. Kotler, M. Kovalcuk, V. Kozhukalov, W. Krah, R. Kralik, M. Kramer, L. Kreczko, F. Krennrich, I. Kreslo, T. Kroupova, S. Kubota, M. Kubu, Y. Kudenko, V. A. Kudryavtsev, G. Kufatty, S. Kuhlmann, J. Kumar, P. Kumar, S. Kumaran, P. Kunze, J. Kunzmann, R. Kuravi, N. Kurita, C. Kuruppu, V. Kus, T. Kutter, J. Kvasnicka, T. Labree, T. Lackey, A. Lambert, B. J. Land, C. E. Lane, N. Lane, K. Lang, T. Langford, M. Langstaff, F. Lanni, O. Lantwin, J. Larkin, P. Lasorak, D. Last, A. Laudrain, A. Laundrie, G. Laurenti, E. Lavaut, A. Lawrence, P. Laycock, I. Lazanu, M. Lazzaroni, T. Le, S. Leardini, J. Learned, T. LeCompte, C. Lee, V. Legin, G. Lehmann Miotto, R. Lehnert, M. A. Leigui de Oliveira, M. Leitner, D. Leon Silverio, L. M. Lepin, J.-Y. Li, S. W. Li, Y. Li, H. Liao, C. S. Lin, D. Lindebaum, S. Linden, R. A. Lineros, J. Ling, A. Lister, B. R. Littlejohn, H. Liu, J. Liu, Y. Liu, S. Lockwitz, M. Lokajicek, I. Lomidze, K. Long, T. V. Lopes, J. Lopez, I. López de Rego, N. López-March, T. Lord, J. M. LoSecco, W. C. Louis, A. Lozano Sanchez, X.-G. Lu, K. B. Luk, B. Lunday, X. Luo, E. Luppi, J. Maalmi, D. MacFarlane, A. A. Machado, P. Machado, C. T. Macias, J. R. Macier, M. MacMahon, A. Maddalena, A. Madera, P. Madigan, S. Magill, C. Magueur, K. Mahn, A. Maio, A. Major, K. Majumdar, M. Man, R. C. Mandujano, J. Maneira, S. Manly, A. Mann, K. Manolopoulos, M. Manrique Plata, S. Manthey Corchado, V. N. Manyam, M. Marchan, A. Marchionni, W. Marciano, D. Marfatia, C. Mariani, J. Maricic, F. Marinho, A. D. Marino, T. Markiewicz, F. Das Chagas Marques, C. Marquet, D. Marsden, M. Marshak, C. M. Marshall, J. Marshall, L. Martina, J. Martín-Albo, N. Martinez, D. A. Martinez Caicedo, F. Martínez López, P. Martínez Miravé, S. Martynenko, V. Mascagna, C. Massari, A. Mastbaum, F. Matichard, S. Matsuno, G. Matteucci, J. Matthews, C. Mauger, N. Mauri, K. Mavrokoridis, I. Mawby, R. Mazza, A. Mazzacane, T. McAskill, N. McConkey, K. S. McFarland, C. McGrew, A. McNab, L. Meazza, V. C. N. Meddage, B. Mehta, P. Mehta, P. Melas, O. Mena, H. Mendez, P. Mendez, D. P. Méndez, A. Menegolli, G. Meng, A. C. E. A. Mercuri, A. Meregaglia, M. D. Messier, S. Metallo, J. Metcalf, W. Metcalf, M. Mewes, H. Meyer, T. Miao, A. Miccoli, G. Michna, V. Mikola, R. Milincic, F. Miller, G. Miller, W. Miller, O. Mineev, A. Minotti, L. Miralles, O. G. Miranda, C. Mironov, S. Miryala, S. Miscetti, C. S. Mishra, S. R. Mishra, A. Mislivec, M. Mitchell, D. Mladenov, I. Mocioiu, A. Mogan, N. Moggi, R. Mohanta, T. A. Mohayai, N. Mokhov, J. Molina, L. Molina Bueno, E. Montagna, A. Montanari, C. Montanari, D. Montanari, D. Montanino, L. M. Montaño Zetina, M. Mooney, A. F. Moor, Z. Moore, D. Moreno, O. Moreno-Palacios, L. Morescalchi, D. Moretti, R. Moretti, C. Morris, C. Mossey, M. Mote, C. A. Moura, G. Mouster, W. Mu, L. Mualem, J. Mueller, M. Muether, F. Muheim, A. Muir, M. Mulhearn, D. Munford, L. J. Munteanu, H. Muramatsu, J. Muraz, M. Murphy, T. Murphy, J. Muse, A. Mytilinaki, J. Nachtman, Y. Nagai, S. Nagu, R. Nandakumar, D. Naples, S. Narita, A. Nath, A. Navrer-Agasson, N. Nayak, M. Nebot-Guinot, A. Nehm, J. K. Nelson, O. Neogi, J. Nesbit, M. Nessi, D. Newbold, M. Newcomer, R. Nichol, F. Nicolas-Arnaldos, A. Nikolica, J. Nikolov, E. Niner, K. Nishimura, A. Norman, A. Norrick, P. Novella, J. A. Nowak, M. Oberling, J. P. Ochoa-Ricoux, S. Oh, S. B. Oh, A. Olivier, A. Olshevskiy, T. Olson, Y. Onel, Y. Onishchuk, A. Oranday, M. Osbiston, J. A. Osorio Vélez, L. Otiniano Ormachea, J. Ott, L. Pagani, G. Palacio, O. Palamara, S. Palestini, J. M. Paley, M. Pallavicini, C. Palomares, S. Pan, P. Panda, W. Panduro Vazquez, E. Pantic, V. Paolone, V. Papadimitriou, R. Papaleo, A. Papanestis, D. Papoulias, S. Paramesvaran, A. Paris, S. Parke, E. Parozzi, S. Parsa, Z. Parsa, S. Parveen, M. Parvu, D. Pasciuto, S. Pascoli, L. Pasqualini, J. Pasternak, C. Patrick, L. Patrizii, R. B. Patterson, T. Patzak, A. Paudel, L. Paulucci, Z. Pavlovic, G. Pawloski, D. Payne, V. Pec, E. Pedreschi, S. J. M. Peeters, W. Pellico, A. Pena Perez, E. Pennacchio, A. Penzo, O. L. G. Peres, Y. F. Perez Gonzalez, L. Pérez-Molina, C. Pernas, J. Perry, D. Pershey, G. Pessina, G. Petrillo, C. Petta, R. Petti, M. Pfaff, V. Pia, L. Pickering, F. Pietropaolo, V. L. Pimentel, G. Pinaroli, J. Pinchault, K. Pitts, K. Plows, R. Plunkett, C. Pollack, T. Pollman, D. Polo-Toledo, F. Pompa, X. Pons, N. Poonthottathil, V. Popov, F. Poppi, J. Porter, M. Potekhin, R. Potenza, J. Pozimski, M. Pozzato, T. Prakash, C. Pratt, M. Prest, F. Psihas, D. Pugnere, X. Qian, J. L. Raaf, V. Radeka, J. Rademacker, B. Radics, A. Rafique, E. Raguzin, M. Rai, S. Rajagopalan, M. Rajaoalisoa, I. Rakhno, L. Rakotondravohitra, L. Ralte, M. A. Ramirez Delgado, B. Ramson, A. Rappoldi, G. Raselli, P. Ratoff, R. Ray, H. Razafinime, E. M. Rea, J. S. Real, B. Rebel, R. Rechenmacher, M. Reggiani-Guzzo, J. Reichenbacher, S. D. Reitzner, H. Rejeb Sfar, E. Renner, A. Renshaw, S. Rescia, F. Resnati, D. Restrepo, C. Reynolds, M. Ribas, S. Riboldi, C. Riccio, G. Riccobene, J. S. Ricol, M. Rigan, E. V. Rincón, A. Ritchie-Yates, S. Ritter, D. Rivera, R. Rivera, A. Robert, J. L. Rocabado Rocha, L. Rochester, M. Roda, P. Rodrigues, M. J. Rodriguez Alonso, J. Rodriguez Rondon, S. Rosauro-Alcaraz, P. Rosier, D. Ross, M. Rossella, M. Rossi, M. Ross-Lonergan, N. Roy, P. Roy, C. Rubbia, A. Ruggeri, G. Ruiz Ferreira, B. Russell, D. Ruterbories, A. Rybnikov, A. Saa-Hernandez, R. Saakyan, S. Sacerdoti, S. K. Sahoo, N. Sahu, P. Sala, N. Samios, O. Samoylov, M. C. Sanchez, A. Sánchez Bravo, P. Sanchez-Lucas, V. Sandberg, D. A. Sanders, S. Sanfilippo, D. Sankey, D. Santoro, N. Saoulidou, P. Sapienza, C. Sarasty, I. Sarcevic, I. Sarra, G. Savage, V. Savinov, G. Scanavini, A. Scaramelli, A. Scarff, T. Schefke, H. Schellman, S. Schifano, P. Schlabach, D. Schmitz, A. W. Schneider, K. Scholberg, A. Schukraft, B. Schuld, A. Segade, E. Segreto, A. Selyunin, C. R. Senise, J. Sensenig, M. H. Shaevitz, P. Shanahan, P. Sharma, R. Kumar, K. Shaw, T. Shaw, K. Shchablo, J. Shen, C. Shepherd-Themistocleous, A. Sheshukov, W. Shi, S. Shin, S. Shivakoti, I. Shoemaker, D. Shooltz, R. Shrock, B. Siddi, M. Siden, J. Silber, L. Simard, J. Sinclair, G. Sinev, Jaydip Singh, J. Singh, L. Singh, P. Singh, V. Singh, S. Singh Chauhan, R. Sipos, C. Sironneau, G. Sirri, K. Siyeon, K. Skarpaas, J. Smedley, E. Smith, J. Smith, P. Smith, J. Smolik, M. Smy, M. Snape, E. L. Snider, P. Snopok, D. Snowden-Ifft, M. Soares Nunes, H. Sobel, M. Soderberg, S. Sokolov, C. J. Solano Salinas, S. Söldner-Rembold, S. R. Soleti, N. Solomey, V. Solovov, W. E. Sondheim, M. Sorel, A. Sotnikov, J. Soto-Oton, A. Sousa, K. Soustruznik, F. Spinella, J. Spitz, N. J. C. Spooner, K. Spurgeon, D. Stalder, M. Stancari, L. Stanco, J. Steenis, R. Stein, H. M. Steiner, A. F. Steklain Lisbôa, A. Stepanova, J. Stewart, B. Stillwell, J. Stock, F. Stocker, T. Stokes, M. Strait, T. Strauss, L. Strigari, A. Stuart, J. G. Suarez, J. Subash, A. Surdo, L. Suter, C. M. Sutera, K. Sutton, Y. Suvorov, R. Svoboda, S. K. Swain, B. Szczerbinska, A. M. Szelc, A. Sztuc, A. Taffara, N. Talukdar, J. Tamara, H. A. Tanaka, S. Tang, N. Taniuchi, A. M. Tapia Casanova, B. Tapia Oregui, A. Tapper, S. Tariq, E. Tarpara, E. Tatar, R. Tayloe, D. Tedeschi, A. M. Teklu, J. Tena Vidal, P. Tennessen, M. Tenti, K. Terao, F. Terranova, G. Testera, T. Thakore, A. Thea, A. Thiebault, S. Thomas, A. Thompson, C. Thorn, S. C. Timm, E. Tiras, V. Tishchenko, N. Todorović, L. Tomassetti, A. Tonazzo, D. Torbunov, M. Torti, M. Tortola, F. Tortorici, N. Tosi, D. Totani, M. Toups, C. Touramanis, D. Tran, R. Travaglini, J. Trevor, E. Triller, S. Trilov, J. Truchon, D. Truncali, W. H. Trzaska, Y. Tsai, Y.-T. Tsai, Z. Tsamalaidze, K. V. Tsang, N. Tsverava, S. Z. Tu, S. Tufanli, C. Tunnell, J. Turner, M. Tuzi, J. Tyler, E. Tyley, M. Tzanov, M. A. Uchida, J. Ureña González, J. Urheim, T. Usher, H. Utaegbulam, S. Uzunyan, M. R. Vagins, P. Vahle, S. Valder, G. A. Valdiviesso, E. Valencia, R. Valentim, Z. Vallari, E. Vallazza, J. W. F. Valle, R. Van Berg, R. G. Van de Water, D. V. Forero, A. Vannozzi, M. Van Nuland-Troost, F. Varanini, D. Vargas Oliva, S. Vasina, N. Vaughan, K. Vaziri, A. Vázquez-Ramos, J. Vega, S. Ventura, A. Verdugo, S. Vergani, M. Verzocchi, K. Vetter, M. Vicenzi, H. Vieira de Souza, C. Vignoli, C. Vilela, E. Villa, S. Viola, B. Viren, A. Vizcaya-Hernandez, T. Vrba, Q. Vuong, A. V. Waldron, M. Wallbank, J. Walsh, T. Walton, H. Wang, J. Wang, L. Wang, M. H. L. S. Wang, X. Wang, Y. Wang, K. Warburton, D. Warner, L. Warsame, M. O. Wascko, D. Waters, A. Watson, K. Wawrowska, A. Weber, C. M. Weber, M. Weber, H. Wei, A. Weinstein, H. Wenzel, S. Westerdale, M. Wetstein, K. Whalen, J. Whilhelmi, A. White, A. White, L. H. Whitehead, D. Whittington, M. J. Wilking, A. Wilkinson, C. Wilkinson, F. Wilson, R. J. Wilson, P. Winter, W. Wisniewski, J. Wolcott, J. Wolfs, T. Wongjirad, A. Wood, K. Wood, E. Worcester, M. Worcester, M. Wospakrik, K. Wresilo, C. Wret, S. Wu, W. Wu, W. Wu, M. Wurm, J. Wyenberg, Y. Xiao, I. Xiotidis, B. Yaeggy, N. Yahlali, E. Yandel, K. Yang, T. Yang, A. Yankelevich, N. Yershov, K. Yonehara, T. Young, B. Yu, H. Yu, J. Yu, Y. Yu, W. Yuan, R. Zaki, J. Zalesak, L. Zambelli, B. Zamorano, A. Zani, O. Zapata, L. Zazueta, G. P. Zeller, J. Zennamo, K. Zeug, C. Zhang, S. Zhang, M. Zhao, E. Zhivun, E. D. Zimmerman, S. Zucchelli, J. Zuklin, V. Zutshi, R. Zwaska and on behalf of the DUNE Collaborationadd Show full author list remove Hide full author list
Instruments 2024, 8(3), 41; https://doi.org/10.3390/instruments8030041 - 11 Sep 2024
Cited by 6 | Viewed by 5674
Abstract
The Module-0 Demonstrator is a single-phase 600 kg liquid argon time projection chamber operated as a prototype for the DUNE liquid argon near detector. Based on the ArgonCube design concept, Module-0 features a novel 80k-channel pixelated charge readout and advanced high-coverage photon detection [...] Read more.
The Module-0 Demonstrator is a single-phase 600 kg liquid argon time projection chamber operated as a prototype for the DUNE liquid argon near detector. Based on the ArgonCube design concept, Module-0 features a novel 80k-channel pixelated charge readout and advanced high-coverage photon detection system. In this paper, we present an analysis of an eight-day data set consisting of 25 million cosmic ray events collected in the spring of 2021. We use this sample to demonstrate the imaging performance of the charge and light readout systems as well as the signal correlations between the two. We also report argon purity and detector uniformity measurements and provide comparisons to detector simulations. Full article
Show Figures

Figure 1

16 pages, 3717 KB  
Article
The Protective Effects of an Aged Black Garlic Water Extract on the Prostate
by Maria Loreta Libero, Antonio J. Montero-Hidalgo, Lucia Recinella, Raúl M. Luque, Daniele Generali, Alessandra Acquaviva, Giustino Orlando, Claudio Ferrante, Luigi Menghini, Simonetta Cristina Di Simone, Nilofar Nilofar, Annalisa Chiavaroli, Luigi Brunetti and Sheila Leone
Nutrients 2024, 16(17), 3025; https://doi.org/10.3390/nu16173025 - 7 Sep 2024
Cited by 6 | Viewed by 8166
Abstract
Chronic inflammation is a recognized risk factor for various cancers, including prostate cancer (PCa). We aim to explore the potential protective effects of aged black garlic extract (ABGE) against inflammation-induced prostate damage and its impact on prostate cancer cell lines. We used an [...] Read more.
Chronic inflammation is a recognized risk factor for various cancers, including prostate cancer (PCa). We aim to explore the potential protective effects of aged black garlic extract (ABGE) against inflammation-induced prostate damage and its impact on prostate cancer cell lines. We used an ex vivo model of inflammation induced by Escherichia coli lipopolysaccharide (LPS) on C57BL/6 male mouse prostate specimens to investigate the anti-inflammatory properties of ABGE. The gene expression levels of pro-inflammatory biomarkers (COX-2, NF-κB, and TNF-α, IL-6) were measured. Additionally, we evaluated ABGE’s therapeutic effects on the prostate cancer cell lines through in vitro functional assays, including colony formation, tumorsphere formation, migration assays, and phosphorylation arrays to assess the signaling pathways (MAPK, AKT, JAK/STAT, and TGF-β). ABGE demonstrated significant anti-inflammatory and antioxidant effects in preclinical models, partly attributed to its polyphenolic content, notably catechin and gallic acid. In the ex vivo model, ABGE reduced the gene expression levels of COX-2, NF-κB, TNF-α, and IL-6. The in vitro studies showed that ABGE inhibited cell proliferation, colony and tumorsphere formation, and cell migration in the prostate cancer cells, suggesting its potential as a therapeutic agent. ABGE exhibits promising anti-inflammatory and anti-cancer properties, supporting further investigation into ABGE as a potential agent for managing inflammation and prostate cancer. Full article
(This article belongs to the Special Issue Effects of Plant Extracts on Human Health)
Show Figures

Figure 1

14 pages, 2524 KB  
Article
Isolation and Characterization of a Frog Virus 3 Strain from a Wood Frog (Rana sylvatica) in Wood Buffalo National Park
by Samantha R. Logan, Sibelle Torres Vilaça, Joe-Felix Bienentreu, Danna M. Schock, David Lesbarrères and Craig R. Brunetti
Viruses 2024, 16(9), 1411; https://doi.org/10.3390/v16091411 - 3 Sep 2024
Cited by 1 | Viewed by 1900
Abstract
Members of the Iridoviridae family, genus Ranavirus, represent a group of globally emerging pathogens of ecological and economic importance. In 2017, an amphibian die-off of wood frogs (Rana sylvatica) and boreal chorus frogs (Pseudacris maculata) was reported in [...] Read more.
Members of the Iridoviridae family, genus Ranavirus, represent a group of globally emerging pathogens of ecological and economic importance. In 2017, an amphibian die-off of wood frogs (Rana sylvatica) and boreal chorus frogs (Pseudacris maculata) was reported in Wood Buffalo National Park, Canada. Isolation and complete genomic sequencing of the tissues of a wood frog revealed the presence of a frog virus 3 (FV3)-like isolate, Rana sylvatica ranavirus (RSR), with a genome size of 105,895 base pairs, 97 predicted open reading frames (ORFs) bearing sequence similarity to FV3 (99.98%) and a FV3-like isolate from a spotted salamander in Maine (SSME; 99.64%). Despite high sequence similarity, RSR had a unique genomic composition containing ORFs specific to either FV3 or SSME. In addition, RSR had a unique 13 amino acid insertion in ORF 49/50L. No differences were found in the in vitro growth kinetics of FV3, SSME, and RSR; however, genomic differences between these isolates were in non-core genes, implicated in nucleic acid metabolism and immune evasion. This study highlights the importance of viral isolation and complete genomic analysis as these not only provide information on ranavirus spatial distribution but may elucidate genomic factors contributing to host tropism and pathogenicity. Full article
(This article belongs to the Special Issue Iridoviruses, 2nd Edition)
Show Figures

Figure 1

7 pages, 905 KB  
Proceeding Paper
The Design of the ENUBET Beamline
by E. G. Parozzi, F. Acerbi, I. Angelis, L. Bomben, M. Bonesini, F. Bramati, A. Branca, C. Brizzolari, G. Brunetti, M. Calviani, S. Carturan, M. G. Catanesi, S. Cecchini, N. Charitonidis, F. Cindolo, G. Cogo, G. Collazuol, F. Dal Corso, C. Delogu, G. De Rosa, A. Falcone, B. Goddard, A. Gola, L. Halić, F. Iacob, C. Jollet, V. Kain, A. Kallitsopoulou, B. Klicek, Y. Kudenko, C. Lampoudis, M. Laveder, P. Legou, A. Longhin, L. Ludovici, E. Lutsenko, L. Magaletti, G. Mandrioli, S. Marangoni, A. Margotti, V. Mascagna, N. Mauri, L. Meazza, A. Meregaglia, M. Mezzetto, M. Nessi, A. Paoloni, M. Pari, T. Papaevangelou, L. Pasqualini, G. Paternoster, L. Patrizii, M. Pozzato, M. Prest, F. Pupilli, E. Radicioni, A. C. Ruggeri, D. Sampsonidis, C. Scian, G. Sirri, M. Stipcevic, M. Tenti, F. Terranova, M. Torti, S. E. Tzamarias, E. Vallazza, F. Velotti and L. Votanoadd Show full author list remove Hide full author list
Phys. Sci. Forum 2023, 8(1), 65; https://doi.org/10.3390/psf2023008065 - 19 Oct 2023
Viewed by 1523
Abstract
The ENUBET project aims to reduce the flux-related systematics to 1% on a narrow band neutrino beam through monitoring the associated charged leptons in an instrumented decay tunnel. A key element of the project is the design of a meson transfer line with [...] Read more.
The ENUBET project aims to reduce the flux-related systematics to 1% on a narrow band neutrino beam through monitoring the associated charged leptons in an instrumented decay tunnel. A key element of the project is the design of a meson transfer line with conventional magnets that maximize the yield of K+ and π+ while minimizing the total length to reduce meson decay outside the instrumented region. In order to limit particle rates in the tunnel instrumentation, a high level of beam collimation is needed, thus allowing non-decayed mesons to reach the end of the tunnel. At the same time, fine-tuning of the shielding and the collimators is required to minimize any beam-induced background in the decay region. The magnetic lattice is optimized with TRANSPORT. The focusing of mesons from the target is performed with a static (quadrupole-based) system that, coupled with a slow proton extraction scheme, allows for a significant pile-up reduction at the tunnel instrumentation while retaining a particle yield large enough for high-precision neutrino cross-section measurements on a 3 year time scale. Charge and momentum selection in an 8.5GeV ± 10% momentum bite is performed by a double dipole system. Shielding elements are optimized with full simulation of the facility in Geant4. In particular, a powerful genetic algorithm is used to scan the parameter space of the collimators automatically in order to find a configuration that minimizes the halo background in the decay tunnel while preserving a large meson yield. This contribution will report the results of the optimization studies and the final design of the ENUBET beamline, together with dose estimation through a FLUKA simulation. The design of an alternative secondary beamline with a broad momentum range (4, 6, and 8.5 GeV/c) that could enhance the physics reach of the facility is additionally discussed. Full article
(This article belongs to the Proceedings of The 23rd International Workshop on Neutrinos from Accelerators)
Show Figures

Figure 1

6 pages, 555 KB  
Proceeding Paper
A Monitored Neutrino Beam at the European Spallation Source
by Francesco Terranova, F. Acerbi, I. Angelis, L. Bomben, M. Bonesini, F. Bramati, A. Branca, C. Brizzolari, G. Brunetti, S. Capelli, S. Carturan, M. G. Catanesi, S. Cecchini, F. Cindolo, G. Cogo, G. Collazuol, F. Dal Corso, C. Delogu, G. De Rosa, A. Falcone, A. Gola, L. Halić, F. Iacob, C. Jollet, A. Kallitsopoulou, B. Klicek, Y. Kudenko, Ch. Lampoudis, M. Laveder, P. Legou, A. Longhin, L. Ludovici, E. Lutsenko, L. Magaletti, G. Mandrioli, A. Margotti, V. Mascagna, S. Marangoni, N. Mauri, L. Meazza, A. Meregaglia, M. Mezzetto, A. Paoloni, T. Papaevangelou, M. Pari, E. G. Parozzi, L. Pasqualini, G. Paternoster, L. Patrizii, M. Pozzato, M. Prest, F. Pupilli, E. Radicioni, A. C. Ruggeri, D. Sampsonidis, C. Scian, G. Sirri, M. Stipcevic, M. Tenti, M. Torti, S. E. Tzamarias, E. Vallazza and L. Votanoadd Show full author list remove Hide full author list
Phys. Sci. Forum 2023, 8(1), 24; https://doi.org/10.3390/psf2023008024 - 25 Jul 2023
Cited by 1 | Viewed by 1641
Abstract
Monitored neutrino beams are facilities where beam diagnostics enable the counting and identification of charged leptons in the decay tunnel of a narrow band beam. These facilities can monitor neutrino production at the single particle level (flux precision <1%) and provide [...] Read more.
Monitored neutrino beams are facilities where beam diagnostics enable the counting and identification of charged leptons in the decay tunnel of a narrow band beam. These facilities can monitor neutrino production at the single particle level (flux precision <1%) and provide information about the neutrino energy at the 10% level. The ENUBET Collaboration has demonstrated that lepton monitoring might be achieved not only by employing kaon decays but also by identifying muons from the π+μ+νμ decays and positrons from the decay-in-flight of muons before the hadron dump. As a consequence, beam monitoring can be performed using the ENUBET technique even when the kaon production yield is kinematically suppressed. This finding opens up a wealth of opportunities for measuring neutrino cross-sections below 1 GeV. In this paper, we investigate this opportunity at the European Spallation Source (ESS), which is an ideal facility to measure νμ and νe cross-sections in the 0.2–1 GeV range. We also describe the planned activities for the design of this beam at the ESS within the framework of the ESSνSB+ design study, which was approved by the EU in July 2022. Full article
(This article belongs to the Proceedings of The 23rd International Workshop on Neutrinos from Accelerators)
Show Figures

Figure 1

5 pages, 4821 KB  
Proceeding Paper
The ENUBET Monitored Neutrino Beam for High Precision Cross-Section Measurements
by C.C. Delogu, F. Acerbi, I. Angelis, L. Bomben, M. Bonesini, F. Bramati, A. Branca, C. Brizzolari, G. Brunetti, M. Calviani, S. Capelli, S. Carturan, M.G. Catanesi, S. Cecchini, N. Charitonidis, F. Cindolo, G. Cogo, G. Collazuol, F. Dal Corso, G. De Rosa, A. Falcone, B. Goddard, A. Gola, L. Halić, F. Iacob, C. Jollet, V. Kain, A. Kallitsopoulou, B. Klicek, Y. Kudenko, Ch. Lampoudis, M. Laveder, P. Legou, A. Longhin, L. Ludovici, E. Lutsenko, L. Magaletti, G. Mandrioli, S. Marangoni, A. Margotti, V. Mascagna, N. Mauri, L. Meazza, A. Meregaglia, M. Mezzetto, M. Nessi, A. Paoloni, M. Pari, T. Papaevangelou, E.G. Parozzi, L. Pasqualini, G. Paternoster, L. Patrizii, M. Pozzato, M. Prest, F. Pupilli, E. Radicioni, A.C. Ruggeri, D. Sampsonidis, C. Scian, G. Sirri, M. Stipcevic, M. Tenti, F. Terranova, M. Torti, S.E. Tzamarias, E. Vallazza, F. Velotti and L. Votanoadd Show full author list remove Hide full author list
Phys. Sci. Forum 2023, 8(1), 8; https://doi.org/10.3390/psf2023008008 - 30 Jun 2023
Viewed by 1334
Abstract
The main source of systematic uncertainty on neutrino cross-section measurements at the GeV scale originates from the poor knowledge of the initial flux. The goal of reducing this uncertainty to 1% can be achieved through the monitoring of charged leptons produced in association [...] Read more.
The main source of systematic uncertainty on neutrino cross-section measurements at the GeV scale originates from the poor knowledge of the initial flux. The goal of reducing this uncertainty to 1% can be achieved through the monitoring of charged leptons produced in association with neutrinos, by properly instrumenting the decay region of a conventional narrow-band neutrino beam. Large-angle muons and positrons from kaons are measured by a sampling calorimeter on the decay tunnel walls, while muon stations after the hadron dump can be used to monitor the neutrino component from pion decays. Furthermore, the narrow momentum width (<10%) of the beam provides a O (10%) measurement of the neutrino energy on an event-by-event basis, thanks to its correlation with the radial position of the interaction at the neutrino detector. The ENUBET project has been funded by the ERC in 2016 to prove the feasibility of such a monitored neutrino beam and, since 2019, ENUBET is also a CERN neutrino platform experiment (NP06/ENUBET). The breakthrough the project achieved is the design of a horn-less neutrino beamline that would allow for a 1% measurement of νe and νμ cross-sections in about 3 years of data taking at CERN-SPS, using ProtoDUNE as far detector. Full article
(This article belongs to the Proceedings of The 23rd International Workshop on Neutrinos from Accelerators)
Show Figures

Figure 1

17 pages, 1013 KB  
Review
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
by Michele Correale, Francesco Fioretti, Lucia Tricarico, Francesca Croella, Natale Daniele Brunetti, Riccardo M. Inciardi, Anna Vittoria Mattioli and Savina Nodari
J. Clin. Med. 2023, 12(11), 3834; https://doi.org/10.3390/jcm12113834 - 3 Jun 2023
Cited by 9 | Viewed by 4941
Abstract
In heart failure with reduced ejection fraction, edema and congestion are related to reduced cardiac function. Edema and congestion are further aggravated by chronic kidney failure and pulmonary abnormalities. Furthermore, together with edema/congestion, sodium/water retention is an important sign of the progression of [...] Read more.
In heart failure with reduced ejection fraction, edema and congestion are related to reduced cardiac function. Edema and congestion are further aggravated by chronic kidney failure and pulmonary abnormalities. Furthermore, together with edema/congestion, sodium/water retention is an important sign of the progression of heart failure. Edema/congestion often anticipates clinical symptoms, such as dyspnea and hospitalization; it is associated with a reduced quality of life and a major risk of mortality. It is very important for clinicians to predict the signs of congestion with biomarkers and, mainly, to understand the pathophysiological findings that underlie edema. Not all congestions are secondary to heart failure, as in nephrotic syndrome. This review summarizes the principal evidence on the possible roles of the old and new congestion biomarkers in HFrEF patients (diagnostic, prognostic, and therapeutic roles). Furthermore, we provide a description of conditions other than congestion with increased congestion biomarkers, in order to aid in reaching a differential diagnosis. To conclude, the review focuses on how congestion biomarkers may be affected by new HF drugs (gliflozins, vericiguat, etc.) approved for HFrEF. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

21 pages, 4745 KB  
Article
Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases
by David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz Guedes, Sandra M. Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Sílvia Chaves and M. Amélia Santos
Int. J. Mol. Sci. 2023, 24(9), 8312; https://doi.org/10.3390/ijms24098312 - 5 May 2023
Cited by 10 | Viewed by 3384
Abstract
With the goal of combating the multi-faceted Alzheimer’s disease (AD), a series of Rivastigmine-Benzimidazole (RIV–BIM) hybrids was recently reported by us as multitarget-directed ligands, thanks to their capacity to tackle important hallmarks of AD. In particular, they exhibited antioxidant activity, acted as cholinesterase [...] Read more.
With the goal of combating the multi-faceted Alzheimer’s disease (AD), a series of Rivastigmine-Benzimidazole (RIV–BIM) hybrids was recently reported by us as multitarget-directed ligands, thanks to their capacity to tackle important hallmarks of AD. In particular, they exhibited antioxidant activity, acted as cholinesterase inhibitors, and inhibited amyloid-β (Aβ) aggregation. Herein, we moved forward in this project, studying their ability to chelate redox-active biometal ions, Cu(II) and Fe(III), with widely recognized roles in the generation of oxidative reactive species and in protein misfolding and aggregation in both AD and Parkinson’s disease (PD). Although Cu(II) chelation showed higher efficiency for the positional isomers of series 5 than those of series 4 of the hybrids, the Aβ-aggregation inhibition appears more dependent on their capacity for fibril intercalation than on copper chelation. Since monoamine oxidases (MAOs) are also important targets for the treatment of AD and PD, the capacity of these hybrids to inhibit MAO-A and MAO-B was evaluated, and they showed higher activity and selectivity for MAO-A. The rationalization of the experimental evaluations (metal chelation and MAO inhibition) was supported by computational molecular modeling studies. Finally, some compounds showed also neuroprotective effects in human neuroblastoma (SH-SY5Y cells) upon treatment with 1-methyl-4-phenylpyridinium (MPP+), a neurotoxic metabolite of a Parkinsonian-inducing agent. Full article
(This article belongs to the Special Issue Advances in Alzheimer’s Disease Drug Research and Development)
Show Figures

Figure 1

23 pages, 3466 KB  
Article
Is the Invasiveness of Pittosporum undulatum in Eucalypt Forests Explained by the Wide Ranging Effects of Its Secondary Metabolites?
by Dalila Pasquini, Luana Beatriz dos Santos Nascimento, Cecilia Brunetti, Francesco Ferrini and Roslyn M. Gleadow
Forests 2023, 14(1), 39; https://doi.org/10.3390/f14010039 - 25 Dec 2022
Cited by 4 | Viewed by 4030
Abstract
Climate change is a driver of biodiversity loss, often favouring invasive species such as in the case of Pittosporum undulatum in Eucalyptus forests of south-eastern Australia. We tested whether the invasiveness of P. undulatum is due to the release of secondary metabolites with [...] Read more.
Climate change is a driver of biodiversity loss, often favouring invasive species such as in the case of Pittosporum undulatum in Eucalyptus forests of south-eastern Australia. We tested whether the invasiveness of P. undulatum is due to the release of secondary metabolites with allelopathic action inhibiting other species germination or to the content of antioxidant secondary metabolites. We compared the germination of P. undulatum and Eucalyptus ovata seeds on different substrates watered with different leachates. Polyphenolic compounds, saponins and tannins of Eucalyptus spp. and P. undulatum leaf extracts were quantified. Biogenic Volatile Organic Compounds were collected in the field and analyzed to compare the emissions in eucalypt forests with and without P. undulatum. Eucalyptus germination rates were not affected by different leachates and no allelopathic compounds were identified in P. undulatum leachate. Flavonoids and tannins characterized Eucalyptus leachates, while P. undulatum leachates showed high hydroxycinnamic acids content. The forests invaded by P. undulatum were characterized by high levels of monoterpenes, whereas the forest lacking P. undulatum were dominated by sesquiterpenes. Our results suggest that the invasiveness of P. undulatum may be due to the high content in secondary metabolites that play a protective role against abiotic stresses rather than the release of allelopathic compounds. Full article
(This article belongs to the Special Issue Biodiversity and Ecosystem Functioning in Forests)
Show Figures

Figure 1

21 pages, 3043 KB  
Article
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8+ T Cell Immunity
by Faye A. Camp, Tonya M. Brunetti, Michelle M. Williams, Jessica L. Christenson, Varsha Sreekanth, James C. Costello, Zachary L. Z. Hay, Ross M. Kedl, Jennifer K. Richer and Jill E. Slansky
Cancers 2022, 14(18), 4397; https://doi.org/10.3390/cancers14184397 - 9 Sep 2022
Cited by 4 | Viewed by 4859
Abstract
Antigenic differences formed by alterations in gene expression and alternative splicing are predicted in breast cancer cells undergoing epithelial to mesenchymal transition (EMT) and the reverse plasticity known as MET. How these antigenic differences impact immune interactions and the degree to which they [...] Read more.
Antigenic differences formed by alterations in gene expression and alternative splicing are predicted in breast cancer cells undergoing epithelial to mesenchymal transition (EMT) and the reverse plasticity known as MET. How these antigenic differences impact immune interactions and the degree to which they can be exploited to enhance immune responses against mesenchymal cells is not fully understood. We utilized a master microRNA regulator of EMT to alter mesenchymal-like EO771 mammary carcinoma cells to a more epithelial phenotype. A computational approach was used to identify neoantigens derived from the resultant differentially expressed somatic variants (SNV) and alternative splicing events (neojunctions). Using whole cell vaccines and peptide-based vaccines, we find superior cytotoxicity against the more-epithelial cells and explore the potential of neojunction-derived antigens to elicit T cell responses through experiments designed to validate the computationally predicted neoantigens. Overall, results identify EMT-associated splicing factors common to both mouse and human breast cancer cells as well as immunogenic SNV- and neojunction-derived neoantigens in mammary carcinoma cells. Full article
(This article belongs to the Special Issue New Insights into Targeted Drugs for Breast Cancer)
Show Figures

Figure 1

16 pages, 3608 KB  
Article
A Facile One-Pot Approach to the Fabrication of Nanocellulose–Titanium Dioxide Nanocomposites with Promising Photocatalytic and Antimicrobial Activity
by Roberta G. Toro, Abeer M. Adel, Tilde de Caro, Bruno Brunetti, Mona T. Al-Shemy and Daniela Caschera
Materials 2022, 15(16), 5789; https://doi.org/10.3390/ma15165789 - 22 Aug 2022
Cited by 19 | Viewed by 3433
Abstract
The combination of cellulosic materials and metal oxide semiconductors can provide composites with superior functional properties compared to cellulose. By using nanocellulose derived from agricultural waste, we propose a one-pot and environmentally friendly approach to the synthesis of nanocellulose–TiO2 (NC–TiO2) [...] Read more.
The combination of cellulosic materials and metal oxide semiconductors can provide composites with superior functional properties compared to cellulose. By using nanocellulose derived from agricultural waste, we propose a one-pot and environmentally friendly approach to the synthesis of nanocellulose–TiO2 (NC–TiO2) nanocomposites with peculiar photocatalytic activity and antibacterial effects. The as-prepared NC–TiO2 composites were fully characterized by different techniques, such as X-ray diffraction (XRD), μ-Raman, Fourier transform infrared spectroscopy (FTIR), thermogravimetry analysis (TGA), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and diffuse reflectance spectroscopy (DRS). The results showed that well crystalline anatase TiO2 nanoparticles of about 5–6 nm were obtained. The photocatalytic activity in particular was evaluated by using methyl orange (MO) solution as a target pollutant at different pH values. It was found that all the tested NC–TiO2 nanocomposites showed stable photocatalytic activity, even after consecutive photocatalytic runs. In addition, NCT nanocomposites with higher TiO2 content showed degradation efficiency of almost 99% towards MO after 180 min of UV illumination. Finally, NC–TiO2 nanocomposites also showed intriguing antimicrobial properties, demonstrating to be effective against Gram-positive (Staphylococcus aureus, Bacillus subtilis) with 20–25 mm of inhibition zone and Gram-negative bacteria (Escherichia coli, Pseudomonas aeuroginosa) with 21–24 mm of inhibition zone, and fungi (Candida albicans) with 9–10 mm of inhibition zone. Full article
(This article belongs to the Special Issue Nanomaterials for the Environmental Remediation of Water and Soil)
Show Figures

Figure 1

14 pages, 793 KB  
Article
Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department
by Marilena Minieri, Vito N. Di Lecce, Maria Stella Lia, Massimo Maurici, Francesca Leonardis, Susanna Longo, Luca Colangeli, Carla Paganelli, Stefania Levantesi, Alessandro Terrinoni, Vincenzo Malagnino, Domenico J. Brunetti, Alfredo Giovannelli, Massimo Pieri, Marco Ciotti, Cartesio D’Agostini, Mariachiara Gabriele, Sergio Bernardini and Jacopo M. Legramante
Diagnostics 2022, 12(8), 1971; https://doi.org/10.3390/diagnostics12081971 - 15 Aug 2022
Cited by 7 | Viewed by 2110
Abstract
In the past two pandemic years, Emergency Departments (ED) have been overrun with COVID-19-suspicious patients. Some data on the role played by laboratory biomarkers in the early risk stratification of COVID-19 patients have been recently published. The aim of this study is to [...] Read more.
In the past two pandemic years, Emergency Departments (ED) have been overrun with COVID-19-suspicious patients. Some data on the role played by laboratory biomarkers in the early risk stratification of COVID-19 patients have been recently published. The aim of this study is to assess the potential role of the new biomarker mid-regional proadrenomedullin (MR-proADM) in stratifying the in-hospital mortality risk of COVID-19 patients at the triage. A further goal of the present study is to evaluate whether MR-proADM together with other biochemical markers could play a key role in assessing the correct care level of these patients. Data from 321 consecutive patients admitted to the triage of the ED with a COVID-19 infection were analyzed. Epidemiological; demographic; clinical; laboratory; and outcome data were assessed. All the biomarkers analyzed showed an important role in predicting mortality. In particular, an increase of MR-proADM level at ED admission was independently associated with a threefold higher risk of IMV. MR-proADM showed greater ROC curves and AUC when compared to other laboratory biomarkers for the primary endpoint such as in-hospital mortality, except for CRP. This study shows that MR-proADM seems to be particularly effective for early predicting mortality and the need of ventilation in COVID-19 patients admitted to the ED. Full article
(This article belongs to the Special Issue Clinical Prognostic and Predictive Biomarkers)
Show Figures

Figure 1

Back to TopTop